<DOC>
	<DOCNO>NCT00659269</DOCNO>
	<brief_summary>Many type chemotherapy may cause nerve damage side effect . This neurotoxicity manifest peripheral sensory neuropathy ( characterized numbness , tingle , pain ) . The goal study determine efficacy combination vitamin B6 B12 prevent chemotherapy induce neuropathy .</brief_summary>
	<brief_title>A Randomized Phase III Study Vitamins B6 B12 Prevent Chemotherapy-Induced Neuropathy Cancer Patients</brief_title>
	<detailed_description>Neuropathy significant side effect chemotherapy use platinum compound , taxanes , vinca alkaloid . There clinical preclinical data vitamin B6 B12 may alleviate neuropathy experimentally induce neuropathy animal model , clinical neuropathy diabetic neuropathy . This randomized phase III study use multivitamin without vitamin B6 B12 prevent relieve neuropathic toxicity chemotherapy patient receive chemotherapy . Patients stratify type chemotherapy agent ( 3 group ) , presence absence neuropathy baseline , randomize receive placebo vitamin B6/B12 supplementation .</detailed_description>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin B 12</mesh_term>
	<mesh_term>Hydroxocobalamin</mesh_term>
	<mesh_term>Vitamin B 6</mesh_term>
	<mesh_term>Pyridoxal</mesh_term>
	<mesh_term>Pyridoxine</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Vinorelbine</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Vinca Alkaloids</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<criteria>1 . All patient , 18 year age old , cancer treat follow drug eligible : Taxanes , vinca alkaloid analog , heavy metal . Each patient allocate follow 3 group : Group 1 ( Heavy metal ) : Patients treat cisplatin ( &gt; 25 mg/m2/week dose intensity ) oxaliplatin Group 2 ( Taxane ) : Patients treat paclitaxel , docetaxel abraxane Group 3 ( Vinca alkaloid ) : Patients treat vincristine vinorelbine . 2 . Patients must life expectancy least 24 week . 3 . Patients must Zubrod performance status 02 . 4 . Patients must sign informed consent . 5 . Patients may grade 0 ( chemotherapy naive ) 1 neuropathy ( history prior chemotherapy ) prior entry . 1 . Patients symptomatic brain metastasis exclude study . 2 . Pregnant woman nurse mother eligible trial . Patients child bear potential must use adequate contraception . 3 . Patients may receive concurrent complementary medicine study . 4 . Patients neuropathy induced diabetes eligible study 5 . Patients severe medical problem uncontrolled diabetes mellitus cardiovascular disease active infection eligible trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Vitamin B-12</keyword>
	<keyword>Vitamin B-6</keyword>
	<keyword>Chemotherapy-Induced Neuropathy</keyword>
	<keyword>Taxanes</keyword>
	<keyword>Vinca alkaloid</keyword>
	<keyword>Heavy metal</keyword>
	<keyword>Neuropathy</keyword>
	<keyword>Nerve pain</keyword>
</DOC>